Submission Details
| 510(k) Number | K871231 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 27, 1987 |
| Decision Date | June 26, 1987 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | — |
K871231 is an FDA 510(k) clearance for the ANTIBODY ASSAY FOR DETECTION OF INFLUENZA B. This device is classified as a Antigens, Cf (including Cf Control), Influenza Virus A, B, C (Class I — General Controls, product code GNX).
Submitted by Microscan Div. Baxter Healthcare Corp. (West Sacramento, US). The FDA issued a Cleared decision on June 26, 1987, 91 days after receiving the submission on March 27, 1987.
This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3330.
| 510(k) Number | K871231 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | March 27, 1987 |
| Decision Date | June 26, 1987 |
| Days to Decision | 91 days |
| Submission Type | Traditional |
| Review Panel | Microbiology (MI) |
| Summary | — |
| Product Code | GNX — Antigens, Cf (including Cf Control), Influenza Virus A, B, C |
| Device Class | Class I — General Controls |
| CFR Regulation | 21 CFR 866.3330 |